Search - tctmd.com

Displaying 21 - 40 of 831

Sort: Relevancy | Date

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Caitlin E. Cox

November 18, 2025

News Conference News AHA 2025

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

Todd Neale

November 17, 2025

News Conference News AHA 2025

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

Todd Neale

November 12, 2025

News Conference News AHA 2025

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

Michael O'Riordan

November 09, 2025

News Conference News AHA 2025

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

Michael O'Riordan

November 08, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

Presentation TCT 2025

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

Presenter: Yiyuan Huang

October 28, 2025

Presentation TCT 2025

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

Presenter: Kuseme Udoh

October 28, 2025

Presentation TCT 2025

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 28, 2025

Presentation TCT 2025

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Presenter: Muhammad Zahid

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

TCT 51: TEMPULSE registry: Temporary Pacing Utility and Safety Evaluation

Presenter: Tomasz Skowerski

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Presenter: Michael Graf

October 28, 2025

Presentation TCT 2025

Same Setting Hybrid Procedures: Pulse Field Ablation and Left Atrial Appendage Closure

Presenter: Shephal K. Doshi

October 28, 2025

Presentation TCT 2025

TCT 1862: Pericardial Tamponade Caused by Rotational Atherectomy Ablation Grinding Through a Barrier Stent Protruding From the Diagonal Artery: A Case Report

Presenter: Minglian Gong

October 28, 2025

Presentation TCT 2025

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

Presenter: Chao Gao

October 28, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Advertisement

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Sham-Controlled Trial, and More, Bolster Pulsed-Field Ablation for AF

DARE-AF Dapagliflozin Fails to Reduce AF Burden After Catheter Ablation

DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients

Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN

What’s Going to Be Hot at AHA 2025?

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

TCT 51: TEMPULSE registry: Temporary Pacing Utility and Safety Evaluation

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Same Setting Hybrid Procedures: Pulse Field Ablation and Left Atrial Appendage Closure

TCT 1862: Pericardial Tamponade Caused by Rotational Atherectomy Ablation Grinding Through a Barrier Stent Protruding From the Diagonal Artery: A Case Report

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content